secwatch.observer — SEC 8-K summary
======================================

Issuer:     Certara, Inc. (CERT)
CIK:        0001827090
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001827090-25-000026
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Certara Q1 2025 revenue up 10% to $106M; net income positive vs year-ago loss
-----------------------------------------------------------------------------

- Revenue $106.0M (+10% YoY); software rev $46.4M (+18%), services $59.6M (+4%).
- Net income $4.7M vs net loss of $4.7M in Q1 2024; adjusted EBITDA $34.8M (+20%).
- Reiterated full-year 2025 financial guidance.
- CEO cites FDA roadmap for reducing animal testing as opportunity for biosimulation.
- CFO notes strong commercial execution despite biopharma headwinds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1827090/000182709025000026/0001827090-25-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1827090/000182709025000026/certara-20250505.htm
  HTML page:      https://secwatch.observer/filing/0001827090-25-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer